Computed tomography screening and lung cancer outcomes
- PMID: 17341709
- DOI: 10.1001/jama.297.9.953
Computed tomography screening and lung cancer outcomes
Erratum in
- JAMA. 2007 Aug 1;298(5):518
Abstract
Context: Current and former smokers are currently being screened for lung cancer with computed tomography (CT), although there are limited data on the effect screening has on lung cancer outcomes. Randomized controlled trials assessing CT screening are currently under way.
Objective: To assess whether screening may increase the frequency of lung cancer diagnosis and lung cancer resection or may reduce the risk of a diagnosis of advanced lung cancer or death from lung cancer.
Design, setting, and participants: Longitudinal analysis of 3246 asymptomatic current or former smokers screened for lung cancer beginning in 1998 either at 1 of 2 academic medical centers in the United States or an academic medical center in Italy with follow-up for a median of 3.9 years.
Intervention: Annual CT scans with comprehensive evaluation and treatment of detected nodules.
Main outcome measures: Comparison of predicted with observed number of new lung cancer cases, lung cancer resections, advanced lung cancer cases, and deaths from lung cancer.
Results: There were 144 individuals diagnosed with lung cancer compared with 44.5 expected cases (relative risk [RR], 3.2; 95% confidence interval [CI], 2.7-3.8; P<.001). There were 109 individuals who had a lung resection compared with 10.9 expected cases (RR, 10.0; 95% CI, 8.2-11.9; P<.001). There was no evidence of a decline in the number of diagnoses of advanced lung cancers (42 individuals compared with 33.4 expected cases) or deaths from lung cancer (38 deaths due to lung cancer observed and 38.8 expected; RR, 1.0; 95% CI, 0.7-1.3; P = .90).
Conclusions: Screening for lung cancer with low-dose CT may increase the rate of lung cancer diagnosis and treatment, but may not meaningfully reduce the risk of advanced lung cancer or death from lung cancer. Until more conclusive data are available, asymptomatic individuals should not be screened outside of clinical research studies that have a reasonable likelihood of further clarifying the potential benefits and risks.
Comment in
-
CT screening for lung cancer: spiraling into confusion?JAMA. 2007 Mar 7;297(9):995-7. doi: 10.1001/jama.297.9.995. JAMA. 2007. PMID: 17341714 No abstract available.
-
Computed tomography screening for lung cancer.JAMA. 2007 Aug 1;298(5):513-4; author reply 515-6. doi: 10.1001/jama.298.5.513-b. JAMA. 2007. PMID: 17666667 No abstract available.
-
Computed tomography screening for lung cancer.JAMA. 2007 Aug 1;298(5):513; author reply 515-6. doi: 10.1001/jama.298.5.513-a. JAMA. 2007. PMID: 17666668 No abstract available.
-
Computed tomography screening for lung cancer.JAMA. 2007 Aug 1;298(5):514-5; author reply 515-6. doi: 10.1001/jama.298.5.514-b. JAMA. 2007. PMID: 17666669 No abstract available.
-
Computed tomography screening for lung cancer.JAMA. 2007 Aug 1;298(5):514; author reply 515-6. doi: 10.1001/jama.298.5.514-a. JAMA. 2007. PMID: 17666670 No abstract available.
-
CT screening for lung cancer.Curr Oncol Rep. 2007 Nov;9(6):501-2. doi: 10.1007/s11912-007-0070-8. Curr Oncol Rep. 2007. PMID: 17991359 No abstract available.
Similar articles
-
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.Lancet Oncol. 2014 Nov;15(12):1342-50. doi: 10.1016/S1470-2045(14)70387-0. Epub 2014 Oct 1. Lancet Oncol. 2014. PMID: 25282284 Clinical Trial.
-
Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.J Formos Med Assoc. 2016 Mar;115(3):163-70. doi: 10.1016/j.jfma.2015.11.007. Epub 2015 Dec 20. J Formos Med Assoc. 2016. PMID: 26714425
-
Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival.Ann Thorac Surg. 2016 May;101(5):1864-9. doi: 10.1016/j.athoracsur.2015.11.001. Epub 2016 Feb 12. Ann Thorac Surg. 2016. PMID: 26876342
-
Lung cancer screening: the radiologist's perspective.Semin Respir Crit Care Med. 2014 Feb;35(1):91-8. doi: 10.1055/s-0033-1363455. Epub 2014 Jan 30. Semin Respir Crit Care Med. 2014. PMID: 24481763 Review.
-
Low-dose CT screening can reduce cancer mortality: A meta-analysis.Rev Assoc Med Bras (1992). 2019 Dec;65(12):1508-1514. doi: 10.1590/1806-9282.65.12.1508. Rev Assoc Med Bras (1992). 2019. PMID: 31994634 Review.
Cited by
-
Bile Acid-conjugate as a Promising Anticancer Agent: Recent Progress.Curr Med Chem. 2024;31(26):4160-4179. doi: 10.2174/0109298673274040231121113410. Curr Med Chem. 2024. PMID: 38173072 Review.
-
Utilization of Diagnostic Procedures After Lung Cancer Screening in the National Lung Screening Trial.J Am Coll Radiol. 2023 Oct;20(10):1022-1030. doi: 10.1016/j.jacr.2023.03.021. Epub 2023 Jul 7. J Am Coll Radiol. 2023. PMID: 37423348 Free PMC article. Clinical Trial.
-
The Diagnostic Accuracy of a Novel Scoring System Using Multi-Detector Computed Tomography to Diagnose Lung Cancer.Cureus. 2023 Mar 6;15(3):e35848. doi: 10.7759/cureus.35848. eCollection 2023 Mar. Cureus. 2023. PMID: 37033527 Free PMC article.
-
Engineered Exosomes for Tumor-Targeted Drug Delivery: A Focus on Genetic and Chemical Functionalization.Pharmaceutics. 2022 Dec 26;15(1):66. doi: 10.3390/pharmaceutics15010066. Pharmaceutics. 2022. PMID: 36678695 Free PMC article. Review.
-
A Comprehensive Survey on the Progress, Process, and Challenges of Lung Cancer Detection and Classification.J Healthc Eng. 2022 Dec 16;2022:5905230. doi: 10.1155/2022/5905230. eCollection 2022. J Healthc Eng. 2022. PMID: 36569180 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
